USPTO serial 79311175
MOLECISION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 15, 2022
- Examiner
- ODUSAMI, OLUWAKEMI KEHINDE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with MOLECISION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
CN
Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
CN
Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
CN
Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Timothy T. Wang
Timothy T. Wang NI, WANG & MASSAND, PLLC8140 WALNUT HILL LANE, SUITE 500DALLAS, TX 75231UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 010 | Blood testing apparatus; Medical apparatus and instruments for monitoring vital signs, blood properties and respiratory events; Medical diagnostic apparatus for testing blood sugar levels, cancer cells, and DNA, incorporating recorded software for performing diagnostic analysis; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood pressure measuring apparatus; apparatus for DNA and RNA testing for medical purposes; blood analyzer; medical genetic testing equipment; diagnostic test equipment for detecting abnormal virus proteins; isotopic equipment and devices for the diagnosis and treatment of disease; special containers for the treatment of medical devices, syringes and other medical pollution wastes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
- Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
- Other trademarks owned by SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.
- Other trademarks in Class 010
- Similar marks named MOLECISION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 23, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jul 22, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jul 22, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| May 15, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 15, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Dec 6, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 30, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 30, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 17, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 17, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 10, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 25, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Oct 25, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Oct 25, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Oct 25, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Oct 25, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 22, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 5, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 5, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 28, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 27, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 25, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 21, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 20, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |